SINOMEDIA(00623) spent HK$781,600 to repurchase 381,000 shares on June 10th.
China Vision Entertainment Group Limited (00623) announced that the company repurchased 381,000 shares on June 10, 2026, at a cost of 781,600 Hong Kong dollars. The repurchase price per share was between 2.04 and 2.06 Hong Kong dollars.
SINOMEDIA (00623) announced that the company repurchased 381,000 shares on June 10, 2026, at a cost of HK $781,600. The repurchase price per share was between HK $2.04 and HK $2.06.
Related Articles
SIPAI HEALTH (00314) repurchased 200,000 shares at a cost of approximately HKD 240,200 on June 10th.
ALPHAMAB-B(09966): The phase III clinical study of Anituximab (KN026) as first-line treatment for HER2-positive advanced breast cancer has reached the primary endpoint.
CSPC PHARMA (01093): The phase III study of the combination of Anetumab ravtansine (KN026) with albumin-bound paclitaxel (HB1801) for first-line treatment for HER2-positive advanced breast cancer has reached its primary endpoint.
SIPAI HEALTH (00314) repurchased 200,000 shares at a cost of approximately HKD 240,200 on June 10th.
ALPHAMAB-B(09966): The phase III clinical study of Anituximab (KN026) as first-line treatment for HER2-positive advanced breast cancer has reached the primary endpoint.
CSPC PHARMA (01093): The phase III study of the combination of Anetumab ravtansine (KN026) with albumin-bound paclitaxel (HB1801) for first-line treatment for HER2-positive advanced breast cancer has reached its primary endpoint.
RECOMMEND
